Home Cart Sign in  
Chemical Structure| 144510-96-3 Chemical Structure| 144510-96-3

Structure of Pixantrone free base
CAS No.: 144510-96-3

Chemical Structure| 144510-96-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pixantrone is an experimental antineoplastic drug.

Synonyms: Pixantrone; BBR 2778 free base

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pixantrone free base

CAS No. :144510-96-3
Formula : C17H19N5O2
M.W : 325.37
SMILES Code : O=C(C1=C(NCCN)C=CC(NCCN)=C12)C3=C(C=NC=C3)C2=O
Synonyms :
Pixantrone; BBR 2778 free base
MDL No. :MFCD09837694

Safety of Pixantrone free base

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Pixantrone free base

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00053105 Lymphoma Phase 1 Unknown - United States, Arizona ... More >> Arizona Clinical Research Center Tucson, Arizona, United States, 85712 United States, Arkansas Highlands Oncology Group Springdale, Arkansas, United States, 72764 United States, California USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90033-0800 United States, Maryland Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5055 United States, Tennessee Boston Baskin Cancer Group, University Tennessee Memphis, Tennessee, United States, 38104 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00069966 Lymphoma Phase 2 Unknown - -
NCT00060684 Lymphoma, Low-Grade ... More >> Lymphoma, Small Lymphocytic Lymphoma, Mixed-Cell, Follicular Lymphoma, Small Cleaved-Cell, Follicular Less << Phase 1 Completed - United States, Arizona ... More >> Arizona Clinical Research Center Tucson, Arizona, United States, 85712 United States, Maryland Greater Baltimore Medical Center Baltimore, Maryland, United States, 21204 United States, New Mexico New Mexico Onc/Hem Consultants, Inc. Albuquerque, New Mexico, United States, 87109 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02678299 Malignant Lymphoma Phase 1 Phase 2 Recruiting - Denmark ... More >> Department of Hematology, Aarhus University Hospital Recruiting Aarhus, Denmark, DK-8000 Contact: Francesco d'Amore, MD DMSci       frandamo@rm.dk Less <<
NCT00551239 Leukemia Lymp... More >>homa Less << Phase 3 Unknown - United States, Washington ... More >> Cell Therapeutics, Incorporated Seattle, Washington, United States, 98119 Less <<
NCT00060671 Lymphoma, Follicular ... More >> Lymphoma, Mixed-Cell, Follicular Lymphoma, Small Cleaved-Cell, Follicular Lymphoma, Low-Grade Less << Phase 3 Terminated - -
NCT00268853 Diffuse Large-Cell Lymphoma Phase 2 Completed - -
NCT03458260 Aggressive Non-Hodgkin Lymphom... More >>a Less << Phase 2 Recruiting March 2025 France ... More >> CH d'Avignon Recruiting Avignon, France Contact: Borhane Slama          Hôpital Haut-Lévèque Recruiting Bordeaux, France Contact: Krimo Bouabdallah          CHRU de Lille Recruiting Lille, France Contact: Franck Morschhauser          CHU Lyon Sud Recruiting Lyon, France Contact: Gilles Salles          CHU de la Conception Recruiting Marseille, France Contact: Vadim Ivanov          Centre Lacassagne Recruiting Nice, France Contact: Antoine Thyss          Hopital La Pitié Salpétriere Recruiting Paris, France Contact: Sylvain Choquet          Hôpital St louis Recruiting Paris, France Contact: Sandy Amorin          CHU de Poitiers Recruiting Poitiers, France Contact: Vincent Delwail          CH de Cornouaille Recruiting Quimper, France Contact: Ronan Le Calloch          CHU de Rouen Recruiting Rouen, France Contact: Hervé Tilly          CHU de Strasbourg Recruiting Strasbourg, France Contact: Luc-Matthieu Fornecker          CHU de Tours Recruiting Tours, France Contact: Emmanuel Gyan Less <<
NCT00577161 Non-Hodgkin's Lymphoma Phase 3 Terminated(closed to enrollmen... More >>t) Less << July 2012 United States, Alabama ... More >> Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States, 35661 United States, California Ventura County Hematology Oncology Specialist Oxnard, California, United States, 93030 United States, Missouri Capitol Comprehensive Cancer Care Jefferson City, Missouri, United States, 65109 Heartland Hematology Oncology Associates Kansas City, Missouri, United States, 64118 United States, New York Cancer Care Center New Albany, New York, United States, 47150 Interlakes Foundation, Inc. Rochester, New York, United States, 14623 United States, Ohio Hematology Oncology Consultants Columbus, Ohio, United States, 43235 United States, Utah Utah Hematology Oncology, P.C. Ogden, Utah, United States, 84403 Less <<
NCT00106600 Acute Myelogenous Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00088530 Lymphoma, Non-Hodgkin Phase 3 Completed - -
NCT00088530 - Completed - -
NCT01632436 Metastatic Cancer Phase 1 Unknown February 2018 United States, Texas ... More >> UTHSCSA-Cancer Therapy-Research Center San Antonio, Texas, United States, 78229 Less <<
NCT01086605 - Completed - -
NCT02499003 Lymphoma, Non-Hodgkin Phase 2 Active, not recruiting October 2021 Germany ... More >> Department of Hematology, Oncology and Pneumology; University Medical Center of the Johannes Gutenberg-University Mainz, RLP, Germany, 55131 Less <<
NCT02800889 Lymphoma Soli... More >>d Tumor (Excluding CNS) Less << Phase 1 Withdrawn(Study withdrawn; no ... More >>participants enrolled) Less << - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Less <<
NCT01086605 Breast Cancer Phase 2 Completed - -
NCT01321541 Diffuse Large B-cell Lymphoma ... More >> de Novo DLBCL DLBCL Transformed From Indolent Lymphoma Follicular Grade 3 Lymphoma Less << Phase 3 Completed - -
NCT01491841 Non-Hodgkin's Lymphoma Phase 1 Phase 2 Active, not recruiting November 2021 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.07mL

0.61mL

0.31mL

15.37mL

3.07mL

1.54mL

30.73mL

6.15mL

3.07mL

References

 

Historical Records

Categories